RBC Capital Starts atai Life Sciences N.V. (ATAI) at Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Credit Suisse Starts atai Life Sciences N.V (ATAI) at Outperform
July 13, 2021 4:17 AM EDTCredit Suisse analyst Judah Frommer initiates coverage on atai Life Sciences N.V (NASDAQ: ATAI) with a Outperform rating and a price target of $25.00.
The analyst comments "We initiate coverage of ATAI with an Outperform rating and a $25 target price. We believe ATAI offers... More
